5.12
-0.20 (-3.76%)
| Previous Close | 5.32 |
| Open | 5.26 |
| Volume | 1,069,841 |
| Avg. Volume (3M) | 1,018,638 |
| Market Cap | 339,517,952 |
| Price / Sales | 20.25 |
| Price / Book | 1.53 |
| 52 Weeks Range | |
| Earnings Date | 20 Aug 2025 |
| Operating Margin (TTM) | -500.53% |
| Diluted EPS (TTM) | -0.910 |
| Quarterly Revenue Growth (YOY) | 10.30% |
| Total Debt/Equity (MRQ) | 4.18% |
| Current Ratio (MRQ) | 5.30 |
| Operating Cash Flow (TTM) | -37.48 M |
| Levered Free Cash Flow (TTM) | -20.36 M |
| Return on Assets (TTM) | -17.89% |
| Return on Equity (TTM) | -30.11% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | NANO-X IMAGING LTD | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | 1.5 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -4.0 |
| Average | -0.50 |
|
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 0.23% |
| % Held by Institutions | 24.70% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Griffin Asset Management, Inc. | 31 Mar 2025 | 183,079 |
| 52 Weeks Range | ||
| Median | 8.00 (56.25%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| D. Boral Capital | 13 Aug 2025 | 8.00 (56.25%) | Buy | 4.55 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| DANIEL RAN | 3.69 | - | 1,000 | 3,690 |
| Aggregate Net Quantity | 1,000 | |||
| Aggregate Net Value ($) | 3,690 | |||
| Aggregate Avg. Buy ($) | 3.69 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| DANIEL RAN | Officer | 05 Sep 2025 | Buy (+) | 1,000 | 3.69 | 3,690 |
| Date | Type | Details |
|---|---|---|
| 12 Aug 2025 | Announcement | Nanox Announces Second Quarter of 2025 Financial Results and Provides Business Update |
| 01 Aug 2025 | Announcement | Nanox to Report Second Quarter 2025 Financial Results on August 12, 2025 |
| 01 Jul 2025 | Announcement | Nanox Announces Clinical and Educational Collaboration with Keiser University Featuring the Nanox.ARC |
| 25 Jun 2025 | Announcement | Q2 Virtual Investor Summit: Presentations Available Now |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |